Company / Total Debt
AVADEL PHARMACEUTICALS PLC Total Debt History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$91.6M
FY2022
5-year range
$91.6M / $142.4M
FY2018-FY2022
Trend
-35.7%
vs FY2021
Sector context
#63 of 83
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's total debt of $92M is lower than 76% of companies in the Health Care sector (FY2022). Improved from $128M to $92M over the past 2 years.
Based on SEC 10-K filings.
$92M in FY2022 with a 5-year CAGR of +221.4%.
Improved from $128M to $92M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -9.0%
- 5-Year CAGR
- +221.4%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 83This company $91.6M Sector average $6.2B
▼
-98.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +221.4%, indicating consistent growth.
- In FY2022, total debt decreased 35.7% year-over-year.
- Ranks #63 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $91.6M | -35.7% |
| FY2021 | $142.4M | +11.1% |
| FY2020 | $128.2M | +5.4% |
| FY2019 | $121.7M | +5.0% |
| FY2018 | $115.8M | +43285.8% |
| FY2017 | $267.0K | -51.2% |
| FY2016 | $547.0K | -20.0% |
| FY2015 | $684.0K | -46.4% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026